Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, BactiQuant AS's Enterprise Value is kr88.33 Mil.
BactiQuant AS's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was kr-12.40 Mil. Therefore, BactiQuant AS's EV-to-EBIT ratio for today is -7.12.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, BactiQuant AS's Enterprise Value is kr88.33 Mil.
BactiQuant AS's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was kr-10.40 Mil. Therefore, BactiQuant AS's EV-to-EBITDA ratio for today is -8.50.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, BactiQuant AS's Enterprise Value is kr88.33 Mil.
BactiQuant AS's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was kr8.32 Mil. Therefore, BactiQuant AS's EV-to-Revenue ratio for today is 10.62.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, BactiQuant AS's Enterprise Value is kr88.33 Mil.
BactiQuant AS's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was kr-10.51 Mil. Therefore, BactiQuant AS's EV-to-FCF ratio for today is -8.41.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
BactiQuant AS (OCSE:BACTIQ) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
BactiQuant AS's current Enterprise Value is kr88.33 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. BactiQuant AS's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was kr-12.40 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
BactiQuant AS's current Enterprise Value is kr88.33 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. BactiQuant AS's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was kr-10.40 Mil.
BactiQuant AS's current Enterprise Value is kr88.33 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. BactiQuant AS's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was kr8.32 Mil.
BactiQuant AS's current Enterprise Value is kr88.33 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. BactiQuant AS's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was kr-10.51 Mil.
BactiQuant AS's current Enterprise Value is kr88.33 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. BactiQuant AS's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was kr-10.51 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BactiQuant AS Enterprise Value Related Terms
BactiQuant AS Enterprise Value Historical Data
* Premium members only.
The historical data trend for BactiQuant AS's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OCSE:BACTIQ vs VLTO, ZWS, CECO: Enterprise Value Comparison
For the Pollution & Treatment Controls subindustry, BactiQuant AS's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BactiQuant AS Enterprise Value vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, BactiQuant AS's Enterprise Value distribution charts can be found below:
* The bar in red indicates where BactiQuant AS's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
BactiQuant AS's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BactiQuant AS (OCSE:BACTIQ) has a Enterprise Value of kr88.33 Mil as of Jun. 30, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on BactiQuant AS and its competitors.
Is BactiQuant AS's Enterprise Value too high?
BactiQuant AS's current Enterprise Value is kr88.33 Mil. Overall, BactiQuant AS has a GF Score™ of 56/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does BactiQuant AS's Enterprise Value compare to VLTO and ZWS?
BactiQuant AS's Enterprise Value of kr88.33 Mil can be compared against companies in the Industrial Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for an Industrial Products company?
A good Enterprise Value depends on the Industrial Products industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on BactiQuant AS and its competitors. BactiQuant AS's current Enterprise Value is kr88.33 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BactiQuant AS stock overvalued right now?
Based on GuruFocus' analysis, BactiQuant AS (OCSE:BACTIQ) is currently considered Fairly Valued. The stock's GF Value™ is kr2.37, compared to a current price of kr2.60 — trading 9.7% above its estimated fair value. The current Enterprise Value is kr88.33 Mil. BactiQuant AS's overall GF Score™ is 56/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For BactiQuant AS (OCSE:BACTIQ), the current Enterprise Value is kr88.33 Mil as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BactiQuant AS (OCSE:BACTIQ) Overvalued in 2026?
Based on GuruFocus' analysis, BactiQuant AS stock appears to be overvalued.
The current stock price of kr2.60 is trading 9.7% above its estimated GF Value™ of kr2.37.
GuruFocus considers BactiQuant AS to be Fairly Valued.
Key valuation signals for OCSE:BACTIQ:
Enterprise Value: kr88.33 Mil
GF Value™: kr2.37 vs. price of kr2.60 (9.7% above fair value)
No single metric tells the full story. See the OCSE:BACTIQ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BactiQuant AS focuses on delivering technology that ensures optimum usage and handling of water around the world. The company's activities include the development, production, sale and service of BactiQuant Online and BactiQuant Mobile Lab with associated test kits/substrate for the quantification and detection of bacteria in water. Its segments are Aquaculture, Data Centres, Oil & Gas, Water Utility, Industry, and Pharma. The group's products are BQ Online 2.0 PRO, BQ Online, BQ Mobile Lab, and Analysis Kits.
56GF Score
Get the complete analysis for OCSE:BACTIQ
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OCSE:BACTIQ has been successfully added to your 
